Immuno-inflammatory markers of syntropic cardiovascular diseases

Immuno-inflammatory markers of syntropic cardiovascular diseases

Objective: To study the immuno-inflammatory markers of coronary heart disease, arterial hypertension and their combined course. The research work included 116 patients with cardiovascular disease of middle and old age. The average age of patients is 62.4±1.27. All patients were examined at the Bukha...

Full description

Bibliographic Details
Main Authors:	Sh. Sh. Ganieva, M. U. Ergasheva, Kh. Sh. Panoev
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-06-01
Series:	Медицинская иммунология
Subjects:	cardiovascular diseases ischemic heart disease arterial hypertension immunity
Online Access:	https://www.mimmun.ru/mimmun/article/view/2763

Similar Items

Salusin-α and salusin-β as new biological markers in cardiovascular diseases: literature review
by: Amina M. Alieva, et al.
Published: (2023-12-01)

Preventive measures for arterial hypertension risk factors among medical staff of Feofaniya Clinical Hospital of State Management of Affairs
by: L. Hordienko, et al.
Published: (2018-06-01)

Preventive measures for arterial hypertension risk factors among medical staff of Feofaniya Clinical Hospital of State Management of Affairs
by: L. Hordienko, et al.
Published: (2018-06-01)

Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension
by: N N Mironchuk, et al.
Published: (2018-04-01)

Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension
by: N.N. Mironchuk, et al.
Published: (2018-04-01)

Outlook from the past to the future
by: E I Chazov
Published: (2004-06-01)

LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
by: Roberto Gabbiadini, et al.
Published: (2023-05-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
by: S. Y. Martsevich
Published: (2015-12-01)

Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases
by: N Yu Grigoryeva, et al.
Published: (2019-01-01)

The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
by: Hannah Zhang, et al.
Published: (2024-01-01)

THE INFLUENCE OF CONCOMITANT CARDIOVASCULAR PATHOLOGY (ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION) ON THE CHANGES OF RIGHT VENTRICLE OF HEART IN MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2012-09-01)

Relationship between noise annoyance from road traffic noise and cardiovascular diseases: A meta-analysis
by: Ana Ndrepepa, et al.
Published: (2011-01-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Recommendations for cardiovascular disease prevention in women: An Indian perspective
by: Zakia Khan, et al.
Published: (2023-01-01)

EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. I. Katelnizkaya, et al.
Published: (2016-01-01)

ORIGINAL PAPER: <br>The lipid disorders therapy in overweight patients
by: Radosław Wilk, et al.
Published: (2005-12-01)

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1)
by: A. S. Safaryan, et al.
Published: (2019-11-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES
by: E. V. Shilova, et al.
Published: (2016-01-01)

Obstructive Sleep Apnea and Cardiovascular Disease: Where Do We Stand?
by: Yüksel Peker, et al.
Published: (2023-06-01)

The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension
by: Anastasiya R. Denisova, et al.
Published: (2022-01-01)

The role of calcium metabolism dysregulation in the pathogenesis of cardiovascular diseases
by: D. E. Mailian, et al.
Published: (2019-09-01)

POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN
by: A. M. Shilov, et al.
Published: (2016-01-01)

Association of healthy lifestyle with incident cardiovascular diseases among hypertensive and normotensive Chinese adults
by: Jian Su, et al.
Published: (2023-03-01)

Cost Analysis of Health Examination Screening Program for Ischemic Heart Disease in Active-Duty Military Personnel in the Middle-Income Country
by: Radoje Simic, et al.
Published: (2021-03-01)

FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

Association of the <i>PSRC1</i> rs599839 Variant with Coronary Artery Disease in a Mexican Population
by: Martha Eunice Rodríguez-Arellano, et al.
Published: (2020-08-01)

Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action
by: Zuraini NZA, et al.
Published: (2021-11-01)

Cardiovascular effects of environmental noise: Research in the United Kingdom
by: Stephen Stansfeld, et al.
Published: (2011-01-01)

ASSESSMENT OF ACHIEVING TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH CORONARY HEART DISEASE AND HYPERTENSION
by: I.M. Hidzynska, et al.
Published: (2020-12-01)

Caracterización de un grupo de hipertensos mayores de 50 años con cardiopatía isquémica asociada Characterization of a group of hypertensive patients over 50 with associated ischemic heart disease
by: Ernesto Groning Roque, et al.
Published: (2004-12-01)

A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial
by: O D Ostroumova, et al.
Published: (2015-12-01)

Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study
by: Chen T, et al.
Published: (2019-03-01)

Radiation-Induced Cardiovascular Disease: A Clinical Perspective
by: Syed Wamique Yusuf, et al.
Published: (2017-10-01)

ASSOCIATIONS OF ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION, AND THEIR IMPORTANCE FOR MORTALITY FROM CARDIOVASCULAR CAUSES AND ALL CAUSES, OF PEOPLE AGED MORE THAN 55 YEARS OLD
by: S. A. Shalnova, et al.
Published: (2015-12-01)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension
by: Alexander V. Sobolev, et al.
Published: (2021-03-01)

Etiopathenogenic bases for the development of pulmonary hypertension and chronic heart failure in patients with ischemic heart disease in combination with arterial hypertension (literature review, observation of the authors)
by: N. A. Matsegora, et al.
Published: (2017-06-01)

Etiopathenogenic bases for the development of pulmonary hypertension and chronic heart failure in patients with ischemic heart disease in combination with arterial hypertension (literature review, observation of the authors)
by: N. A. Matsegora, et al.
Published: (2017-06-01)

Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases
by: Ioana Mozos, et al.
Published: (2017-08-01)